Clinical Trial Management System (CTMS) Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End-use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers) and By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global clinical trial management system (CTMS) market was valued at US$ 727.54 million in 2018 and is expected to reach US$ 2478.15 million by 2027, growing at an estimated CAGR of 14.6% over the forecast period. Rising number of clinical trial is driving the clinical trial management system market. Increase in the number of clinical trials each year is witnessed by the life science industry. This growth in the CTMS market can be attributed to factors such as high popularity of chronic diseases, government funds availability for clinical trials, increasing R&D investment in pharmaceutical industry.
Clinical trial is a medical research study performed on humans to test the safety and efficacy of drugs, devices and therapeutic products before launching it in the market. Proper management of clinical trials has become a priority for pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers because of its major advantages. It not only manages the data but also standardizes the entire process. Clinical trial management system is a software solution for management, storage and analysis of the clinical data. It also provide data for business intelligence system .It utilizes the huge unstructured data generated during the clinical trials to analyze and store by using different models of simulation and regression. CTMS helps in maintaining and managing the clinical trials conducted by different pharmaceutical industries, and clinical research organizations. These systems make it easy to track and monitor the patients involved in clinical trial, site selection, and analyzing vast data.
CTMS software is important to monitor and control clinical trial activity and to provide a real-time overview of the operations. Professionals in the healthcare and pharmaceutical field who use CTMS can track the procedure, study progress, administrative issues and financial information consistently.
Improving managerial control in clinical trials by IT based clinical trial management solutions will further boost the demand of clinical trial management system market in coming years. Increase in adoption of CTMS in future is expected due to its ability to manage complex protocol designs and reduction in timeline by streamlining processes. Business growth is also favoured by government efforts to invite multinational corporations for directing clinical trials to attract foreign reserves for financial and technological improvements. Integration of CTMS with hospital information system provides more precise and time saving documentation.
On the other hand, long approval time and high cost for clinical trials, difficulties in recruiting and enrolling the patients for clinical trial are certain areas of concern in the Clinical Trial Management System (CTMS) Market. Approvals from Institutional Review Boards (IRB), availability of patient population for the respective clinical study, legal reviews, and protocol designs are certain factors which can delay the drug approval process. Increasing regulatory requirements in certain countries are responsible for creating complexity in clinical trial. Such factors are anticipated to critically impact the overall Clinical Trial Management System (CTMS) Market over the next eight years.
The clinical trial management system is also engaged in providing dashboards to communicate trial performance along with other necessary operational costs.
CTMS Market, by component
Based on components, clinical trial management system (CTMS) market is segmented into hardware, software and services. The software segment is expected to expand with a significant CAGR over the forecast period, as it helps to streamline and fine-tune the document management processes. The software platform performs critical functions such as detailed trial preparation management, progress at country and site, reporting operations, and supply and finance.
An effective clinical trial management system (CTMS) software solution can help pharmaceutical and medical device companies to comply with regulatory norms, which helps to further accelerate the market entry for software providers.
CTMS Market, By End user
Based on end user, clinical trial management system (CTMS) market is segmented into, pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers.The category of clinical research organizations is expected to grow is with a significant CAGR over the forecast period. Growth of the segment is accelerated due to the growing acceptance of clinical trial management systems in the new drug development process for clinical studies. Collaborations between biopharmaceutical companies and clinical research organizations (CROs) is responsible for increasing the number of ongoing clinical trials. Rising government grants to support clinical trials, availability of innovative , clinical trial management system (CTMS) solutions and growing customer base for Clinical Trial Management System (CTMS) Market solutions are the major factors responsible for the adoption of clinical trial management system by pharmaceutical and biopharmaceutical firms and ultimately promising growth in the future.
CTMS Market, By Product
Based on product type, the Clinical Trial Management System (CTMS) Market is segmented into enterprise and site based. The enterprise based segment is expected to grow with a significant CAGR over the forecast period, due to its benefits such as tracking and management of regulatory processes and enhanced billing compliances. It helps to bring consistency in budgets and provides strong support for financial management.
CTMS Market, By Delivery mode
Based on delivery mode, clinical trial management system (CTMS) market is segmented into, Web, Cloud, and On Premise. Growth is expected in web-based clinical trial management over the forecast period, due to its user-friendliness, high functional flexibility, cost-effectiveness and increased efficiency of clinical trials.
Moreover, the cloud-based clinical trial management system (CTMS) market is now gradually being implemented by most major pharmaceutical and biotech companies. The increased adoption of cloud-based clinical trial management system (CTMS) is because companies don't need to bear huge costs associated with buying servers, installing and validating software, and maintaining them.
BSI (Business Systems Integration AG) offers a cloud or on-premise approach to CTMS. Its functionality improves the operations of the clinical trials from initial planning, execution, reporting, patient tracking and full documentation.
Geographical Analysis
North America's clinical trial management system industry dominated the global Clinical Trial Management System (CTMS) Market, due to increasing number of clinical trials coupled with increasing funding from NIH for clinical research. Companies ' focus on R&D activities will increase demand for a clinical trial management system, thereby increasing regional growth
Moreover, Asia Pacific is also estimated to witness the significant percent of CAGR over the forecast period, due to the presence of a diverse pool of patients and low operating costs of conducting clinical trials in countries like China and India. Increasing numbers of clinical trials being carried out in the region will also favour the growth of the industry. Government is taking efforts in APAC region to improve healthcare infrastructure and enhance medicine research and development activities coupled with the growing trend of clinical trial outsourcing are accelerating the region's growth.
Countries in Central and Eastern Europe provide opportunities for life science companies to conduct clinical trials. Improvement in industry regulatory laws and patent expiration laws in countries like Japan, China, and India is leading to expansion of clinical trial in Asia Pacific, which is responsible for reduction in cost of conducting clinical trials compared to Europe and U.S.
Global Clinical trials management system in healthcare market revenue & forecast, (US$ Million), 2015 – 2027
Competitive Landscape
Some of the key industry players operational in the Clinical Trial Management System (CTMS) Market includes Bio Clinica, Medidata Solutions, DataTrak Internationals, Bio-Optronics, Merge Healthcare (IBM Watson), DSG, Forte Research Systems, MedNet Solutions, Omnicomm Systems, Oracle, MasterControl, Parexel Informatics and Veeva Systems. Industry players implement strategies including partnerships, mergers and acquisitions that assist them in maintaining their market position. For instance, in July 2016, Bio Clinica announced acquisition of Compass Research, a U.S. based clinical research network that has direct access to specific population with neurodegenerative disorder and other disorders. This strategy rendered company with sustainable profits and strengthened its market position.
Clinical Trial Management System (CTMS) in Healthcare Market:
- By Component type
- Software
- Hardware
- Services
- By Delivery mode
- Web
- Cloud
- On-Premise
- By Product
- Enterprise Based
- Site Based Services
- By End-user
- Pharmaceutical & Biopharmaceutical Companies
- Clinical Research Organizations
- Healthcare Providers
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Clinical Trial Management System (CTMS) Market
6. Market
Synopsis: Clinical Trial Management
System (CTMS) Market
7. Clinical
Trial Management System (CTMS) Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Clinical Trial Management System (CTMS) Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Clinical Trial Management System (CTMS) Market
7.6. Porter’s
Five Force Analysis
8. Global
Clinical Trial Management System (CTMS) Market Analysis and Forecasts, 2019 –
2027
8.1. Overview
8.1.1. Global
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
8.2. Global
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
8.2.1. Software
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Hardware
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Services
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Component type
9. Global
Clinical Trial Management System (CTMS) Market Analysis and Forecasts, 2019 –
2027
9.1. Overview
9.2. Global
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
9.2.1. Web
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Cloud
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. On-Premise
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2018
9.2.3.3. Market
Forecast, 2019 – 2027
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2018
9.2.3.5.1.2. Market
Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2018
9.2.3.5.2.2. Market
Forecast, 2019 – 2027
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2018
9.2.3.5.3.2. Market
Forecast, 2019 – 2027
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2018
9.2.3.5.4.2. Market
Forecast, 2019 – 2027
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2018
9.2.3.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key Segment
for Channeling Investments
9.3.1. By
Delivery mode
10. Global
Clinical Trial Management System (CTMS) Market Analysis and Forecasts, 2019 –
2027
10.1. Overview
10.2. Global
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
10.2.1. Enterprise
Based
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Site
Based
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.2.3. Services
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2018
10.2.3.3. Market
Forecast, 2019 – 2027
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2018
10.2.3.5.1.2. Market
Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2018
10.2.3.5.2.2. Market
Forecast, 2019 – 2027
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2018
10.2.3.5.3.2. Market
Forecast, 2019 – 2027
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2018
10.2.3.5.4.2. Market
Forecast, 2019 – 2027
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2018
10.2.3.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By
Product
11. Global
Clinical Trial Management System (CTMS) Market Analysis and Forecasts, 2019 –
2027
11.1. Overview
11.2. Global
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
11.2.1. Pharmaceutical
and Biopharmaceutical Companies
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2018
11.2.1.3. Market
Forecast, 2019 – 2027
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2018
11.2.1.5.1.2. Market
Forecast, 2019 – 2027
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2018
11.2.1.5.2.2. Market
Forecast, 2019 – 2027
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2018
11.2.1.5.3.2. Market
Forecast, 2019 – 2027
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2018
11.2.1.5.4.2. Market
Forecast, 2019 – 2027
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2018
11.2.1.5.5.2. Market
Forecast, 2019 – 2027
11.2.2. Clinical
Research Organizations
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2018
11.2.2.3. Market
Forecast, 2019 – 2027
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2018
11.2.2.5.1.2. Market
Forecast, 2019 – 2027
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2018
11.2.2.5.2.2. Market
Forecast, 2019 – 2027
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2018
11.2.2.5.3.2. Market
Forecast, 2019 – 2027
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2018
11.2.2.5.4.2. Market
Forecast, 2019 – 2027
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2018
11.2.2.5.5.2. Market
Forecast, 2019 – 2027
11.2.3. Healthcare
Providers
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2018
11.2.3.3. Market
Forecast, 2019 – 2027
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2018
11.2.3.5.1.2. Market
Forecast, 2019 – 2027
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2018
11.2.3.5.2.2. Market
Forecast, 2019 – 2027
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2018
11.2.3.5.3.2. Market
Forecast, 2019 – 2027
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2018
11.2.3.5.4.2. Market
Forecast, 2019 – 2027
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2018
11.2.3.5.5.2. Market
Forecast, 2019 – 2027
11.3. Key
Segment for Channeling Investments
11.3.1. By
End-user
12. North
America Clinical Trial Management System (CTMS) Market Analysis and Forecasts,
2019 - 2027
12.1. Overview
12.1.1. North
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
12.2. North
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
12.2.1. Software
12.2.2. Hardware
12.2.3. Services
12.3. North
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
12.3.1. Web
12.3.2. Cloud
12.3.3. On-Premise
12.4. North America
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
12.4.1. Enterprise
Based
12.4.2. Site
Based
12.4.3. Services
12.5. North
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
12.5.1. Pharmaceutical
and Biopharmaceutical Companies
12.5.2. Clinical
Research Organizations
12.5.3. Healthcare
Providers
12.6. North
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
12.6.1.1.1. Software
12.6.1.1.2. Hardware
12.6.1.1.3. Services
12.6.1.2. U.S
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
12.6.1.2.1. Web
12.6.1.2.2. Cloud
12.6.1.2.3. On-Premise
12.6.1.3. U.S
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
12.6.1.3.1. Enterprise
Based
12.6.1.3.2. Site
Based
12.6.1.3.3. Services
12.6.1.4. U.S
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
12.6.1.4.1. Pharmaceutical
and Biopharmaceutical Companies
12.6.1.4.2. Clinical
Research Organizations
12.6.1.4.3. Healthcare
Providers
12.6.2. Canada
12.6.2.1. Canada
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
12.6.2.1.1. Software
12.6.2.1.2. Hardware
12.6.2.1.3. Services
12.6.2.2. Canada
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
12.6.2.2.1. Web
12.6.2.2.2. Cloud
12.6.2.2.3. On-Premise
12.6.2.3. Canada
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
12.6.2.3.1. Enterprise
Based
12.6.2.3.2. Site
Based
12.6.2.3.3. Services
12.6.2.4. Canada
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
12.6.2.4.1. Pharmaceutical
and Biopharmaceutical Companies
12.6.2.4.2. Clinical
Research Organizations
12.6.2.4.3. Healthcare
Providers
12.6.3. Mexico
12.6.3.1. Mexico
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
12.6.3.1.1. Software
12.6.3.1.2. Hardware
12.6.3.1.3. Services
12.6.3.2. Mexico
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
12.6.3.2.1. Web
12.6.3.2.2. Cloud
12.6.3.2.3. On-Premise
12.6.3.3. Mexico
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
12.6.3.3.1. Enterprise
Based
12.6.3.3.2. Site
Based
12.6.3.3.3. Services
12.6.3.4. Mexico
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
12.6.3.4.1. Pharmaceutical
and Biopharmaceutical Companies
12.6.3.4.2. Clinical
Research Organizations
12.6.3.4.3. Healthcare
Providers
12.6.4. Rest of
North America
12.6.4.1. Rest
of North America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Component type
12.6.4.1.1. Software
12.6.4.1.2. Hardware
12.6.4.1.3. Services
12.6.4.2. Rest
of North America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Delivery mode
12.6.4.2.1. Web
12.6.4.2.2. Cloud
12.6.4.2.3. On-Premise
12.6.4.3. Rest
of North America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Product
12.6.4.3.1. Enterprise
Based
12.6.4.3.2. Site
Based
12.6.4.3.3. Services
12.6.4.4. Rest
of North America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By End-user
12.6.4.4.1. Pharmaceutical
and Biopharmaceutical Companies
12.6.4.4.2. Clinical
Research Organizations
12.6.4.4.3. Healthcare
Providers
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Component type
12.7.3. By
Delivery mode
12.7.4. By
Product
12.7.5. By
End-user
13. Europe
Clinical Trial Management System (CTMS) Market Analysis and Forecasts, 2019 -
2027
13.1. Overview
13.1.1. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
13.2. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
13.2.1. Software
13.2.2. Hardware
13.2.3. Services
13.3. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
13.3.1. Web
13.3.2. Cloud
13.3.3. On-Premise
13.4. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
13.4.1. Enterprise
Based
13.4.2. Site
Based
13.4.3. Services
13.5. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
13.5.1. Pharmaceutical
and Biopharmaceutical Companies
13.5.2. Clinical
Research Organizations
13.5.3. Healthcare
Providers
13.6. Europe
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Country
13.6.1. France
13.6.1.1. France
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
13.6.1.1.1. Software
13.6.1.1.2. Hardware
13.6.1.1.3. Services
13.6.1.2. France
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
13.6.1.2.1. Web
13.6.1.2.2. Cloud
13.6.1.2.3. On-Premise
13.6.1.3. France
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
13.6.1.3.1. Enterprise
Based
13.6.1.3.2. Site
Based
13.6.1.3.3. Services
13.6.1.4. France
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
13.6.1.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.1.4.2. Clinical
Research Organizations
13.6.1.4.3. Healthcare
Providers
13.6.2. The UK
13.6.2.1. The
UK Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
13.6.2.1.1. Software
13.6.2.1.2. Hardware
13.6.2.1.3. Services
13.6.2.2. The
UK Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
13.6.2.2.1. Web
13.6.2.2.2. Cloud
13.6.2.2.3. On-Premise
13.6.2.3. The
UK Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.2.3.1. Enterprise
Based
13.6.2.3.2. Site
Based
13.6.2.3.3. Services
13.6.2.4. The
UK Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
13.6.2.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.2.4.2. Clinical
Research Organizations
13.6.2.4.3. Healthcare
Providers
13.6.3. Spain
13.6.3.1. Spain
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
13.6.3.1.1. Software
13.6.3.1.2. Hardware
13.6.3.1.3. Services
13.6.3.2. Spain
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
13.6.3.2.1. Web
13.6.3.2.2. Cloud
13.6.3.2.3. On-Premise
13.6.3.3. Spain
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
13.6.3.3.1. Enterprise
Based
13.6.3.3.2. Site
Based
13.6.3.3.3. Services
13.6.3.4. Spain
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
13.6.3.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.3.4.2. Clinical
Research Organizations
13.6.3.4.3. Healthcare
Providers
13.6.4. Germany
13.6.4.1. Germany
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
13.6.4.1.1. Software
13.6.4.1.2. Hardware
13.6.4.1.3. Services
13.6.4.2. Germany
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
13.6.4.2.1. Web
13.6.4.2.2. Cloud
13.6.4.2.3. On-Premise
13.6.4.3. Germany
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
13.6.4.3.1. Enterprise
Based
13.6.4.3.2. Site
Based
13.6.4.3.3. Services
13.6.4.4. Germany
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
13.6.4.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.4.4.2. Clinical
Research Organizations
13.6.4.4.3. Healthcare
Providers
13.6.5. Italy
13.6.5.1. Italy
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
13.6.5.1.1. Software
13.6.5.1.2. Hardware
13.6.5.1.3. Services
13.6.5.2. Italy
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
13.6.5.2.1. Web
13.6.5.2.2. Cloud
13.6.5.2.3. On-Premise
13.6.5.3. Italy
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
13.6.5.3.1. Enterprise
Based
13.6.5.3.2. Site
Based
13.6.5.3.3. Services
13.6.5.4. Italy
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
13.6.5.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.5.4.2. Clinical
Research Organizations
13.6.5.4.3. Healthcare
Providers
13.6.6. Nordic
Countries
13.6.6.1. Nordic
Countries Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
13.6.6.1.1. Software
13.6.6.1.2. Hardware
13.6.6.1.3. Services
13.6.6.2. Nordic
Countries Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
13.6.6.2.1. Web
13.6.6.2.2. Cloud
13.6.6.2.3. On-Premise
13.6.6.3. Nordic
Countries Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.6.3.1. Enterprise
Based
13.6.6.3.2. Site
Based
13.6.6.3.3. Services
13.6.6.4. Nordic
Countries Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
13.6.6.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.6.4.2. Clinical
Research Organizations
13.6.6.4.3. Healthcare
Providers
13.6.6.5. Nordic
Countries Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux
Union Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
13.6.7.1.1. Software
13.6.7.1.2. Hardware
13.6.7.1.3. Services
13.6.7.2. Benelux
Union Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
13.6.7.2.1. Web
13.6.7.2.2. Cloud
13.6.7.2.3. On-Premise
13.6.7.3. Benelux
Union Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.7.3.1. Enterprise
Based
13.6.7.3.2. Site
Based
13.6.7.3.3. Services
13.6.7.4. Benelux
Union Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
13.6.7.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.7.4.2. Clinical
Research Organizations
13.6.7.4.3. Healthcare
Providers
13.6.7.5. Benelux
Union Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest
of Europe Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
13.6.8.1.1. Software
13.6.8.1.2. Hardware
13.6.8.1.3. Services
13.6.8.2. Rest
of Europe Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
13.6.8.2.1. Web
13.6.8.2.2. Cloud
13.6.8.2.3. On-Premise
13.6.8.3. Rest
of Europe Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.8.3.1. Enterprise
Based
13.6.8.3.2. Site
Based
13.6.8.3.3. Services
13.6.8.4. Rest
of Europe Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
13.6.8.4.1. Pharmaceutical
and Biopharmaceutical Companies
13.6.8.4.2. Clinical
Research Organizations
13.6.8.4.3. Healthcare
Providers
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Component type
13.7.3. By
Delivery mode
13.7.4. By
Product
13.7.5. By
End-user
14. Asia
Pacific Clinical Trial Management System (CTMS) Market Analysis and Forecasts,
2019 - 2027
14.1. Overview
14.1.1. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
14.2. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
14.2.1. Software
14.2.2. Hardware
14.2.3. Services
14.3. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
14.3.1. Web
14.3.2. Cloud
14.3.3. On-Premise
14.4. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
14.4.1. Enterprise
Based
14.4.2. Site
Based
14.4.3. Services
14.5. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
14.5.1. Pharmaceutical
and Biopharmaceutical Companies
14.5.2. Clinical
Research Organizations
14.5.3. Healthcare
Providers
14.6. Asia
Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.1. China
14.6.1.1. China
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
14.6.1.1.1. Software
14.6.1.1.2. Hardware
14.6.1.1.3. Services
14.6.1.2. China
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
14.6.1.2.1. Web
14.6.1.2.2. Cloud
14.6.1.2.3. On-Premise
14.6.1.3. China
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
14.6.1.3.1. Enterprise
Based
14.6.1.3.2. Site
Based
14.6.1.3.3. Services
14.6.1.4. China
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
14.6.1.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.1.4.2. Clinical
Research Organizations
14.6.1.4.3. Healthcare
Providers
14.6.2. Japan
14.6.2.1. Japan
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts, By
Component type
14.6.2.1.1. Software
14.6.2.1.2. Hardware
14.6.2.1.3. Services
14.6.2.2. Japan
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
14.6.2.2.1. Web
14.6.2.2.2. Cloud
14.6.2.2.3. On-Premise
14.6.2.3. Japan
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
14.6.2.3.1. Enterprise
Based
14.6.2.3.2. Site
Based
14.6.2.3.3. Services
14.6.2.4. Japan
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
14.6.2.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.2.4.2. Clinical
Research Organizations
14.6.2.4.3. Healthcare
Providers
14.6.3. India
14.6.3.1. India
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
14.6.3.1.1. Software
14.6.3.1.2. Hardware
14.6.3.1.3. Services
14.6.3.2. India
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
14.6.3.2.1. Web
14.6.3.2.2. Cloud
14.6.3.2.3. On-Premise
14.6.3.3. India
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
14.6.3.3.1. Enterprise
Based
14.6.3.3.2. Site
Based
14.6.3.3.3. Services
14.6.3.4. India
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
14.6.3.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.3.4.2. Clinical
Research Organizations
14.6.3.4.3. Healthcare
Providers
14.6.4. New
Zealand
14.6.4.1. New
Zealand Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
14.6.4.1.1. Software
14.6.4.1.2. Hardware
14.6.4.1.3. Services
14.6.4.2. New
Zealand Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
14.6.4.2.1. Web
14.6.4.2.2. Cloud
14.6.4.2.3. On-Premise
14.6.4.3. New
Zealand Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.4.3.1. Enterprise
Based
14.6.4.3.2. Site
Based
14.6.4.3.3. Services
14.6.4.4. New
Zealand Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
14.6.4.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.4.4.2. Clinical
Research Organizations
14.6.4.4.3. Healthcare
Providers
14.6.5. Australia
14.6.5.1. Australia
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
14.6.5.1.1. Software
14.6.5.1.2. Hardware
14.6.5.1.3. Services
14.6.5.2. Australia
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
14.6.5.2.1. Web
14.6.5.2.2. Cloud
14.6.5.2.3. On-Premise
14.6.5.3. Australia
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
14.6.5.3.1. Enterprise
Based
14.6.5.3.2. Site
Based
14.6.5.3.3. Services
14.6.5.4. Australia
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
14.6.5.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.5.4.2. Clinical
Research Organizations
14.6.5.4.3. Healthcare
Providers
14.6.6. South
Korea
14.6.6.1. South
Korea Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
14.6.6.1.1. Software
14.6.6.1.2. Hardware
14.6.6.1.3. Services
14.6.6.2. South
Korea Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
14.6.6.2.1. Web
14.6.6.2.2. Cloud
14.6.6.2.3. On-Premise
14.6.6.3. South
Korea Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.6.3.1. Enterprise
Based
14.6.6.3.2. Site
Based
14.6.6.3.3. Services
14.6.6.4. South
Korea Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
14.6.6.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.6.4.2. Clinical
Research Organizations
14.6.6.4.3. Healthcare
Providers
14.6.7. Southeast
Asia
14.6.7.1. Southeast
Asia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
14.6.7.1.1. Software
14.6.7.1.2. Hardware
14.6.7.1.3. Services
14.6.7.2. Southeast
Asia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
14.6.7.2.1. Web
14.6.7.2.2. Cloud
14.6.7.2.3. On-Premise
14.6.7.3. Southeast
Asia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.7.3.1. Enterprise
Based
14.6.7.3.2. Site
Based
14.6.7.3.3. Services
14.6.7.4. Southeast
Asia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
14.6.7.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.7.4.2. Clinical
Research Organizations
14.6.7.4.3. Healthcare
Providers
14.6.7.5. Southeast
Asia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest
of Asia Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Component type
14.6.8.1.1. Software
14.6.8.1.2. Hardware
14.6.8.1.3. Services
14.6.8.2. Rest
of Asia Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Delivery mode
14.6.8.2.1. Web
14.6.8.2.2. Cloud
14.6.8.2.3. On-Premise
14.6.8.3. Rest
of Asia Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Product
14.6.8.3.1. Enterprise
Based
14.6.8.3.2. Site
Based
14.6.8.3.3. Services
14.6.8.4. Rest
of Asia Pacific Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By End-user
14.6.8.4.1. Pharmaceutical
and Biopharmaceutical Companies
14.6.8.4.2. Clinical
Research Organizations
14.6.8.4.3. Healthcare
Providers
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Component type
14.7.3. By
Delivery mode
14.7.4. By
Product
14.7.5. By
End-user
15. Middle
East and Africa Clinical Trial Management System (CTMS) Market Analysis and
Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Middle
East and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
15.2. Middle
East and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Component type
15.2.1. Software
15.2.2. Hardware
15.2.3. Services
15.3. Middle
East and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Delivery mode
15.3.1. Web
15.3.2. Cloud
15.3.3. On-Premise
15.4. Middle
East and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By Product
15.4.1. Enterprise
Based
15.4.2. Site
Based
15.4.3. Services
15.5. Middle
East and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
and Forecasts, By End-user
15.5.1. Pharmaceutical
and Biopharmaceutical Companies
15.5.2. Clinical
Research Organizations
15.5.3. Healthcare
Providers
15.6. Middle East
and Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi
Arabia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
15.6.1.1.1. Software
15.6.1.1.2. Hardware
15.6.1.1.3. Services
15.6.1.2. Saudi
Arabia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
15.6.1.2.1. Web
15.6.1.2.2. Cloud
15.6.1.2.3. On-Premise
15.6.1.3. Saudi
Arabia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.1.3.1. Enterprise
Based
15.6.1.3.2. Site
Based
15.6.1.3.3. Services
15.6.1.4. Saudi
Arabia Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
15.6.1.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.1.4.2. Clinical
Research Organizations
15.6.1.4.3. Healthcare
Providers
15.6.2. UAE
15.6.2.1. UAE
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
15.6.2.1.1. Software
15.6.2.1.2. Hardware
15.6.2.1.3. Services
15.6.2.2. UAE
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
15.6.2.2.1. Web
15.6.2.2.2. Cloud
15.6.2.2.3. On-Premise
15.6.2.3. UAE
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
15.6.2.3.1. Enterprise
Based
15.6.2.3.2. Site
Based
15.6.2.3.3. Services
15.6.2.4. UAE
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
15.6.2.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.2.4.2. Clinical
Research Organizations
15.6.2.4.3. Healthcare
Providers
15.6.3. Egypt
15.6.3.1. Egypt
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
15.6.3.1.1. Software
15.6.3.1.2. Hardware
15.6.3.1.3. Services
15.6.3.2. Egypt
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts, By
Delivery mode
15.6.3.2.1. Web
15.6.3.2.2. Cloud
15.6.3.2.3. On-Premise
15.6.3.3. Egypt
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
15.6.3.3.1. Enterprise
Based
15.6.3.3.2. Site
Based
15.6.3.3.3. Services
15.6.3.4. Egypt
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts, By
End-user
15.6.3.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.3.4.2. Clinical
Research Organizations
15.6.3.4.3. Healthcare
Providers
15.6.4. Kuwait
15.6.4.1. Kuwait
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
15.6.4.1.1. Software
15.6.4.1.2. Hardware
15.6.4.1.3. Services
15.6.4.2. Kuwait
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
15.6.4.2.1. Web
15.6.4.2.2. Cloud
15.6.4.2.3. On-Premise
15.6.4.3. Kuwait
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
15.6.4.3.1. Enterprise
Based
15.6.4.3.2. Site
Based
15.6.4.3.3. Services
15.6.4.4. Kuwait
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
15.6.4.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.4.4.2. Clinical
Research Organizations
15.6.4.4.3. Healthcare
Providers
15.6.5. South
Africa
15.6.5.1. South
Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
15.6.5.1.1. Software
15.6.5.1.2. Hardware
15.6.5.1.3. Services
15.6.5.2. South
Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
15.6.5.2.1. Web
15.6.5.2.2. Cloud
15.6.5.2.3. On-Premise
15.6.5.3. South
Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.5.3.1. Enterprise
Based
15.6.5.3.2. Site
Based
15.6.5.3.3. Services
15.6.5.4. South
Africa Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
15.6.5.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.5.4.2. Clinical
Research Organizations
15.6.5.4.3. Healthcare
Providers
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest
of Middle East & Africa Clinical Trial Management System (CTMS) Market
Revenue (US$ Mn) and Forecasts, By Component type
15.6.6.1.1. Software
15.6.6.1.2. Hardware
15.6.6.1.3. Services
15.6.6.2. Rest
of Middle East & Africa Clinical Trial Management System (CTMS) Market
Revenue (US$ Mn) and Forecasts, By Delivery mode
15.6.6.2.1. Web
15.6.6.2.2. Cloud
15.6.6.2.3. On-Premise
15.6.6.3. Rest
of Middle East & Africa Clinical Trial Management System (CTMS) Market
Revenue (US$ Mn) and Forecasts, By Product
15.6.6.3.1. Enterprise
Based
15.6.6.3.2. Site
Based
15.6.6.3.3. Services
15.6.6.4. Rest
of Middle East & Africa Clinical Trial Management System (CTMS) Market
Revenue (US$ Mn) and Forecasts, By End-user
15.6.6.4.1. Pharmaceutical
and Biopharmaceutical Companies
15.6.6.4.2. Clinical
Research Organizations
15.6.6.4.3. Healthcare
Providers
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Component type
15.7.3. By
Delivery mode
15.7.4. By
Product
15.7.5. By
End-user
16. Latin
America Clinical Trial Management System (CTMS) Market Analysis and Forecasts,
2019 - 2027
16.1. Overview
16.1.1. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn)
16.2. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Component type
16.2.1. Software
16.2.2. Hardware
16.2.3. Services
16.3. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Delivery mode
16.3.1. Web
16.3.2. Cloud
16.3.3. On-Premise
16.4. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Product
16.4.1. Enterprise
Based
16.4.2. Site
Based
16.4.3. Services
16.5. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By End-user
16.5.1. Pharmaceutical
and Biopharmaceutical Companies
16.5.2. Clinical
Research Organizations
16.5.3. Healthcare
Providers
16.6. Latin
America Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and
Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
16.6.1.1.1. Software
16.6.1.1.2. Hardware
16.6.1.1.3. Services
16.6.1.2. Brazil
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
16.6.1.2.1. Web
16.6.1.2.2. Cloud
16.6.1.2.3. On-Premise
16.6.1.3. Brazil
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
16.6.1.3.1. Enterprise
Based
16.6.1.3.2. Site
Based
16.6.1.3.3. Services
16.6.1.4. Brazil
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
16.6.1.4.1. Pharmaceutical
and Biopharmaceutical Companies
16.6.1.4.2. Clinical
Research Organizations
16.6.1.4.3. Healthcare
Providers
16.6.2. Argentina
16.6.2.1. Argentina
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Component type
16.6.2.1.1. Software
16.6.2.1.2. Hardware
16.6.2.1.3. Services
16.6.2.2. Argentina
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Delivery mode
16.6.2.2.1. Web
16.6.2.2.2. Cloud
16.6.2.2.3. On-Premise
16.6.2.3. Argentina
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By Product
16.6.2.3.1. Enterprise
Based
16.6.2.3.2. Site
Based
16.6.2.3.3. Services
16.6.2.4. Argentina
Clinical Trial Management System (CTMS) Market Revenue (US$ Mn) and Forecasts,
By End-user
16.6.2.4.1. Pharmaceutical
and Biopharmaceutical Companies
16.6.2.4.2. Clinical
Research Organizations
16.6.2.4.3. Healthcare
Providers
16.6.3. Rest of
Latin America
16.6.3.1. Rest
of Latin America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Component type
16.6.3.1.1. Software
16.6.3.1.2. Hardware
16.6.3.1.3. Services
16.6.3.2. Rest
of Latin America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Delivery mode
16.6.3.2.1. Web
16.6.3.2.2. Cloud
16.6.3.2.3. On-Premise
16.6.3.3. Rest
of Latin America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By Product
16.6.3.3.1. Enterprise
Based
16.6.3.3.2. Site
Based
16.6.3.3.3. Services
16.6.3.4. Rest
of Latin America Clinical Trial Management System (CTMS) Market Revenue (US$
Mn) and Forecasts, By End-user
16.6.3.4.1. Pharmaceutical
and Biopharmaceutical Companies
16.6.3.4.2. Clinical
Research Organizations
16.6.3.4.3. Healthcare
Providers
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Component type
16.7.3. By
Delivery mode
16.7.4. By
Product
16.7.5. By
End-user
17. Competitive
Benchmarking
17.1. Market
Share Analysis, 2018
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player
Profiles
18.1. Bio
Clinica Inc
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Bio-Optronics,
Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. DataTrak
Internationals, Inc.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. DSG Inc.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Forte
Research Systems Inc.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Master
Control Inc.
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Medidata
Solutions, Inc.
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. MedNet
Solutions, Inc
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Merge
healthcare (IBM Watson)
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Omnicomm
Systems Inc.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Oracle
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Parexel
Informatics, Inc.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. Veeva
Systems Inc.
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Other
Market Participants
19. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.